TriSalus CFO uses shares to cover tax withholding

TriSalus Life Sciences, Inc. Chief Financial Officer David Patience reported a routine tax-related share withholding.

Rhea-AI Filing Summary

TriSalus Life Sciences, Inc. Chief Financial Officer David Patience reported a routine tax-related share withholding. The company withheld 14,650 shares of common stock at $4.46 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. Following this transaction, Patience directly holds 261,107 shares of TriSalus common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 14,650 shares

Exercise Price or Tax Liability 1 txn

Insider Patience David

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	14,650	$4.46	$65K

Holdings After Transaction: Common Stock — 261,107 shares (Direct)

Footnotes (1)

1. F1. Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units previously granted.

Key Figures

Shares withheld for taxes: 14,650 shares Withholding price per share: $4.46 per share Shares held after transaction: 261,107 shares

3 metrics

Shares withheld for taxes 14,650 shares Tax withholding on RSU vesting; transaction code F

Withholding price per share $4.46 per share Value used for tax-withholding disposition

Shares held after transaction 261,107 shares Direct common stock ownership following withholding

Key Terms

restricted stock units, tax withholding obligations, Chief Financial Officer

3 terms

restricted stock units financial

"in connection with the vesting of restricted stock units previously granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations"

Chief Financial Officer financial

"officer_title": "Chief Financial Officer""

A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did TriSalus (TLSI) CFO David Patience report in this Form 4?

The Form 4 shows CFO David Patience had 14,650 TriSalus shares withheld to cover taxes from vesting restricted stock units. This is a non-market tax-withholding disposition, not an open-market sale, and reflects routine equity compensation treatment.

Was the TriSalus (TLSI) CFO’s Form 4 transaction a stock sale?

No, the transaction was not an open-market stock sale. Shares were withheld by TriSalus to satisfy David Patience’s tax withholding obligations on vesting restricted stock units, classified as a tax-withholding disposition under code F on the Form 4.

How many TriSalus (TLSI) shares were withheld for the CFO’s taxes?

TriSalus withheld 14,650 shares of common stock for CFO David Patience’s tax obligations. The withholding relates specifically to the vesting of previously granted restricted stock units, as described in the Form 4 footnote disclosure.

How many TriSalus (TLSI) shares does the CFO hold after this Form 4 event?

After the tax-withholding transaction, CFO David Patience directly holds 261,107 TriSalus common shares. This figure reflects his remaining direct ownership following the 14,650-share withholding to satisfy tax obligations on restricted stock unit vesting.

What does transaction code F mean in the TriSalus (TLSI) CFO Form 4?

Transaction code F indicates shares used to pay an exercise price or tax liability. In this case, it signifies TriSalus withheld 14,650 shares from CFO David Patience to meet tax obligations from vesting restricted stock units, not a discretionary market sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 04:01 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Patience David

(Last) (First) (Middle)

6272 W. 91ST AVENUE

(Street)

WESTMINSTER COLORADO 80031

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TriSalus Life Sciences, Inc. [ TLSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		F		14,650(1)	D	$4.46	261,107	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units previously granted.

Remarks:

	/s/ David Patience	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)